Rasopathy
Gene: SPRED1
Multiple affected individuals reported, deletions account for ~10% of causative variants. Legius syndrome is characterised by multiple cafe-au-lait spots, sometimes associated with skin fold freckling, variable dysmorphic features such as hypertelorism or macrocephaly, lipomas, and mild learning disabilities or attention problems. It is not associated with neurofibromas, optic gliomas, Lisch nodules, or tumor predisposition. The SPRED1 gene encodes a negative regulator of the RAS-MAPK pathway, similar to neurofibromin.Created: 11 Sep 2020, 10:10 p.m. | Last Modified: 11 Sep 2020, 10:10 p.m.
Panel Version: 0.83
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Legius syndrome, MIM# 611431
Publications
Gene: spred1 has been classified as Green List (High Evidence).
Phenotypes for gene: SPRED1 were changed from to Legius syndrome, MIM# 611431
Publications for gene: SPRED1 were set to
Mode of inheritance for gene: SPRED1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
gene: SPRED1 was added gene: SPRED1 was added to Rasopathy_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SPRED1 was set to Unknown